中华结核和呼吸杂志
中華結覈和呼吸雜誌
중화결핵화호흡잡지
Chinese Journal of Tuberculosis and Respiratory Diseases
2010年
10期
750-753
,共4页
陈亚红%姚婉贞%康健%蔡柏蔷%周新%刘政%陈萍%孙德俊%郑劲平%王国扬%冯玉麟%徐永健%贾燕%路明%常春%王筱宏
陳亞紅%姚婉貞%康健%蔡柏薔%週新%劉政%陳萍%孫德俊%鄭勁平%王國颺%馮玉麟%徐永健%賈燕%路明%常春%王篠宏
진아홍%요완정%강건%채백장%주신%류정%진평%손덕준%정경평%왕국양%풍옥린%서영건%가연%로명%상춘%왕소굉
肺疾病,慢性阻塞性%认知%治疗
肺疾病,慢性阻塞性%認知%治療
폐질병,만성조새성%인지%치료
Pulmonary disease,chronic obstructive%Cognition%Therapy
目的 研究COPD患者的治疗状况及自我认知情况.方法 2007年9月至2008年12月在全国11家医院进行多中心问卷调查,内容包括患者对治疗目标的认知、既往治疗方法和对治疗药物的期望.采用描述性统计方法进行统计学分析.结果 共回收调查问卷2072份,有效问卷1698份.以听说过COPD的653例为基准分析,其中59.1%(384/650)的患者认为COPD的治疗目标是减轻症状;近3个月应用异丙托溴铵、噻托溴铵和茶碱缓释片治疗的患者分别占39.8%(260/653)、27.1%(177/653)和53.7%(351/653);72.0%(465/646)的患者遵医嘱服药;80%以上的患者不知道抗胆碱能药物、β2-受体激动剂、吸入糖皮质激素、吸入糖皮质激素/长效β2-受体激动剂、茶碱有无不良反应;37.4%(240/641)的患者担心吸入糖皮质激素有不良反应;42.2%(274/650)的患者经常服用抗生素,60.1%(391/651)的患者家中没有供氧设备,70.5%(457/648)的患者未接受过呼吸康复训练;77.4%(500/646)的患者认为COPD需要长期规律治疗;79.6%(481/604)的患者认为药效(效果好、起效快和作用时间长)在理想药物中居首位;16.9%(78/461)的患者认为,在既往使用过的治疗COPD的药物中,氟替卡松/沙美特罗或嚷托溴锼是最理想的药物.结论 COPD患者对疾病相关知识的知晓程度较低,应加强对患者的认知教育工作.
目的 研究COPD患者的治療狀況及自我認知情況.方法 2007年9月至2008年12月在全國11傢醫院進行多中心問捲調查,內容包括患者對治療目標的認知、既往治療方法和對治療藥物的期望.採用描述性統計方法進行統計學分析.結果 共迴收調查問捲2072份,有效問捲1698份.以聽說過COPD的653例為基準分析,其中59.1%(384/650)的患者認為COPD的治療目標是減輕癥狀;近3箇月應用異丙託溴銨、噻託溴銨和茶堿緩釋片治療的患者分彆佔39.8%(260/653)、27.1%(177/653)和53.7%(351/653);72.0%(465/646)的患者遵醫囑服藥;80%以上的患者不知道抗膽堿能藥物、β2-受體激動劑、吸入糖皮質激素、吸入糖皮質激素/長效β2-受體激動劑、茶堿有無不良反應;37.4%(240/641)的患者擔心吸入糖皮質激素有不良反應;42.2%(274/650)的患者經常服用抗生素,60.1%(391/651)的患者傢中沒有供氧設備,70.5%(457/648)的患者未接受過呼吸康複訓練;77.4%(500/646)的患者認為COPD需要長期規律治療;79.6%(481/604)的患者認為藥效(效果好、起效快和作用時間長)在理想藥物中居首位;16.9%(78/461)的患者認為,在既往使用過的治療COPD的藥物中,氟替卡鬆/沙美特囉或嚷託溴鎪是最理想的藥物.結論 COPD患者對疾病相關知識的知曉程度較低,應加彊對患者的認知教育工作.
목적 연구COPD환자적치료상황급자아인지정황.방법 2007년9월지2008년12월재전국11가의원진행다중심문권조사,내용포괄환자대치료목표적인지、기왕치료방법화대치료약물적기망.채용묘술성통계방법진행통계학분석.결과 공회수조사문권2072빈,유효문권1698빈.이은설과COPD적653례위기준분석,기중59.1%(384/650)적환자인위COPD적치료목표시감경증상;근3개월응용이병탁추안、새탁추안화다감완석편치료적환자분별점39.8%(260/653)、27.1%(177/653)화53.7%(351/653);72.0%(465/646)적환자준의촉복약;80%이상적환자불지도항담감능약물、β2-수체격동제、흡입당피질격소、흡입당피질격소/장효β2-수체격동제、다감유무불량반응;37.4%(240/641)적환자담심흡입당피질격소유불량반응;42.2%(274/650)적환자경상복용항생소,60.1%(391/651)적환자가중몰유공양설비,70.5%(457/648)적환자미접수과호흡강복훈련;77.4%(500/646)적환자인위COPD수요장기규률치료;79.6%(481/604)적환자인위약효(효과호、기효쾌화작용시간장)재이상약물중거수위;16.9%(78/461)적환자인위,재기왕사용과적치료COPD적약물중,불체잡송/사미특라혹양탁추수시최이상적약물.결론 COPD환자대질병상관지식적지효정도교저,응가강대환자적인지교육공작.
Objective To investigate the attitudes and actions of patients with chronic obstructive pulmonary disease (COPD) on treatment. Methods A nation-wide multi-center, questionnaire study was carried out to investigate the patient understanding and experience of COPD treatment between Sep. 2007 and Dec. 2008. The questionnaire included the patients' understanding of goal of COPD treatment, previous treatment, and expectation on drugs. The data were analyzed by descriptive statistical methods. Results 2072 patients with COPD in 11 centers were interviewed in the study. The final effective questionnaires were collected from 1698 cases. 653 patients had known of COPD. The attitudes and actions on treatment were analyzed based on these patients. The patients had different understanding of goals for COPD treatment,including 59. 1% (384/650) for relieving symptoms. In recent 3 months, the most commonly used drugs were theophlline (53. 7%, 351/653), iprotropium (39. 8%, 260/653), tiotropium (27. 1%, 177/653).72. 0% (465/646) patients used the drugs according to the prescriptions. There were more than 80%patients who did not understand the side effects of anti-cholinergics, β-adrenergic agonists, inhaled steroids,inhaled steroid/long-acting β-agonist combination therapy, or theophyllines. 37.4% (240/641) patients were afraid of side effects of inhaled steroids. 42. 2% (274/650) patients often took antibiotics. There was no oxygen supply at home in 60. 1% (391/651) patients. 70.5% (457/648) did not have pulmonary rehabilitation. Requirement of long-term regular treatment was considered in 77.4% ( 500/646 ) patients.The most important thing about patients' attitude on ideal drugs for COPD was drug efficacy (79. 6% , 481/604). The most ideal drug used in the past was fluticasone/salmeterol or tiotropium ( 16. 9%, 78/461 ).Conclusions Patients had different attitudes and actions on COPD treatment. Patient education should be strengthened to realize treatment goals for COPD.
